Antitumor and Antimetastatic Activities of Docetaxel Are Enhanced by Genistein through Regulation of Osteoprotegerin/Receptor Activator of Nuclear Factor-kappa B (RANK)/RANK Ligand/MMP-9 Signaling in Prostate Cancer (Retraction of Vol 66, Pg 4816, 2006)

Kucuk O.; Hussain M.; Abrams J.; Cher M. L.; Li Y.; Sarkar F. H.

首页> 外文期刊>Cancer research: The official organ of the American Association for Cancer Research, Inc >Antitumor and Antimetastatic Activities of Docetaxel Are Enhanced by Genistein through Regulation of Osteoprotegerin/Receptor Activator of Nuclear Factor-kappa B (RANK)/RANK Ligand/MMP-9 Signaling in Prostate Cancer (Retraction of Vol 66, Pg 4816, 2006)

【24h】

Antitumor and Antimetastatic Activities of Docetaxel Are Enhanced by Genistein through Regulation of Osteoprotegerin/Receptor Activator of Nuclear Factor-kappa B (RANK)/RANK Ligand/MMP-9 Signaling in Prostate Cancer (Retraction of Vol 66, Pg 4816, 2006)

机译：Genistein通过调节核因子 - κB（等级）/ Rank配体/ MMP-9在前列腺癌中的调节来增强多西紫杉醇的抗肿瘤和抗致致催化剂活化剂（RANCE癌症中的信号传导（ROR 66，PG 4816,2006）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer research: The official organ of the American Association for Cancer Research, Inc》 |2018年第18期|共1页
作者
Kucuk O.; Hussain M.; Abrams J.; Cher M. L.; Li Y.; Sarkar F. H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献

1. Antitumor and Antimetastatic Activities of Docetaxel Are Enhanced by Genistein through Regulation of Osteoprotegerin/Receptor Activator of Nuclear Factor-kappa B (RANK)/RANK Ligand/MMP-9 Signaling in Prostate Cancer (Retraction of Vol 66, Pg 4816, 2006) [J] . Kucuk O., Hussain M., Abrams J., Cancer research: The official organ of the American Association for Cancer Research, Inc . 2018,第18期

机译：Genistein通过调节核因子 - κB（等级）/ Rank配体/ MMP-9在前列腺癌中的调节来增强多西紫杉醇的抗肿瘤和抗致致催化剂活化剂（RANCE癌症中的信号传导（ROR 66，PG 4816,2006）
2. Expression profile of receptor activator of nuclear-κb (rank), rank ligand (rankl) and osteoprotegerin (OPG) in breast cancer [J] . Anticancer Research: International Journal of Cancer Research and Treatment . 2013,第1期

机译：乳腺癌中核-κb受体受体激活剂（rank），秩配体（rankl）和骨保护素（OPG）的表达特征
3. Expression profile of receptor activator of nuclear-κb (rank), rank ligand (rankl) and osteoprotegerin (OPG) in breast cancer [J] . Anticancer Research: International Journal of Cancer Research and Treatment . 2013,第1期

机译：乳腺癌中核-κb受体受体激活剂（rank），秩配体（rankl）和骨保护素（OPG）的表达特征
4. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway [O] . Xiao-Feng He, Long Zhang, Chun-Hua Zhang, 2017

机译：小ber碱通过NF-kB受体激活剂/ NF-kB配体/骨保护素（RANK / RANKL / OPG）受体激活剂减轻骨质疏松大鼠的氧化应激
5. Retraction: Antitumor and Antimetastatic Activities of Docetaxel Are Enhanced by Genistein through Regulation of Osteoprotegerin/Receptor Activator of Nuclear Factor-κB (RANK)/RANK Ligand/MMP-9 Signaling in Prostate Cancer [O] . 2018

机译：收缩：Genistein通过调节核因子-κB（等级）/ Rank配体/ MMP-9信号传导的核心蛋白来增强多西紫杉醇的抗肿瘤和抗致常规活性。

Antitumor and Antimetastatic Activities of Docetaxel Are Enhanced by Genistein through Regulation of Osteoprotegerin/Receptor Activator of Nuclear Factor-kappa B (RANK)/RANK Ligand/MMP-9 Signaling in Prostate Cancer (Retraction of Vol 66, Pg 4816, 2006)

著录项

相似文献

相关主题

期刊订阅